1309035-89-9

Upstream product

• 99-96-7 4-hydroxy-benzoic acid 
• 94168-82-8 N-1'-(1'-methoxycarbonyl-2'-phenylethyl)-4-hydroxybenzamide 
• 7524-50-7 methyl (2S)-2-amino-3-phenylpropanoate hydrochloride 

Downstream Products

• 934221-65-5 N-(N-4-(2-(dimethylamino)ethoxy)benzoyl-L-phenylalanyl)-L-phenylalanine methyl ester 
• 934221-15-5 N-(N-4-hydroxybenzoyl-L-phenylalanyl)-L-phenylalanol 
• 934221-64-4 N-(N-4-(2-(dimethylamino)ethoxy)benzoyl-L-phenylalanyl)-L-phenylalanol 
• 934221-16-6 N-(N-5''-hydroxybenzoyl-L-phenylalanyl)-L-phenylalanine methyl ester 
• 934221-77-9 sodium N-(N-5''-hydroxybenzoyl-L-phenylalanyl)-L-phenylalaninate 

Relevant academic research and scientific papers

Synthesis and anti-tumor activity evaluation of Matijin-Su derivatives

A series of Matijin-Su (MTS, N-(N-benzoyl-l-phenylalanyl)-O-acetyl-l- phenylalanol) derivatives was synthesized and evaluated for their anti-tumor activities in hepatocellular carcinoma cells. The IC50 of compounds 1, 3, 4, 11, 13 were less than 20 μM, and compound 1 and 3 showed an IC 50 value of less than 9 μM. Expansion inhibition could be found significantly in compound 1 and 3-treated human hepatoma cell HepG2 and PLC/PRF/5, while both compounds exhibit lower toxicity to human hepatocyte cell line L-02. Compound 1 and 3 could induce cell cycle arrest at G1/S phase. This may be attributed to increase level of intracellular reactive oxygen species (ROS). Up-regulation of p38 MAPK activity in responding the ROS stabilize p53 and activate p21 transcription, the critical regulatory in G1/S checkpoint. Observations in this study shed light on the potential of MTS derivatives compound 1 and 3 as novel suppressors to human liver cancer.

Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents

A series of Matijing-Su (MTS, N-(N-benzoyl-l-phenylalanyl)-O-acetyl-l- phenylalanol) derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity in 2.2.15 cells. The IC50 of compounds 14a (0.71 μM), 13c (2.85 μM), 13b (4.37 μM), etc. and the selective index of 13g (161.01), 13c (90.45), 13a (85.09) etc. of the inhibition on the replication of HBV DNA were better than those of the positive control lamivudine (IC50: 82.42 μM, SI: 41.59). Compounds 13o, 13p, and 16a also exhibited significant anti-HBV activity.